📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer. (2015)

First Author: Guttery DS

Attributed to: The Development of Inhibitors of Cdk Activating Kinase (CAK) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1373/clinchem.2015.238717

PubMed Identifier: 25979954

Publication URI: http://europepmc.org/abstract/MED/25979954

Type: Journal Article/Review

Volume: 61

Parent Publication: Clinical chemistry

Issue: 7

ISSN: 0009-9147